The FDA issued an RFI seeking venture capital input on a new contract model to connect portfolio companies directly with ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
The U.S. FDA’s final guidance for clinical trial inspections conducted under the bioresearch monitoring (BiMo) program seems to deviate little if at all from the 2024 draft, but that is precisely the ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
SAN FRANCISCO--(BUSINESS WIRE)--Mandolin, the leading AI automation platform for specialty drug access, announced that it has raised $40 million in funding from Greylock Partners, SignalFire, Maverick ...
News-Medical.Net on MSN
Simple reminder emails increase clinicians' use of database for safe opioid prescribing
A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback